Analysts forecast that Nutrien Ltd (NYSE:NTR) will announce earnings per share (EPS) of $0.48 for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Nutrien’s earnings, with the highest EPS estimate coming in at $0.54 and the lowest estimate coming in at $0.42. Nutrien posted earnings of $0.47 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 2.1%. The business is expected to report its next quarterly earnings results on Monday, November 4th.
On average, analysts expect that Nutrien will report full-year earnings of $2.88 per share for the current year, with EPS estimates ranging from $2.75 to $3.13. For the next financial year, analysts expect that the business will report earnings of $3.48 per share, with EPS estimates ranging from $3.20 to $3.68. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for Nutrien.
Nutrien (NYSE:NTR) last released its earnings results on Monday, July 29th. The company reported $1.58 EPS for the quarter, missing the Zacks’ consensus estimate of $1.59 by ($0.01). The firm had revenue of $8.66 billion during the quarter, compared to the consensus estimate of $8.17 billion. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.48 EPS.
Several institutional investors and hedge funds have recently modified their holdings of NTR. Boston Partners grew its holdings in shares of Nutrien by 39.4% in the first quarter. Boston Partners now owns 12,584,872 shares of the company’s stock worth $663,978,000 after acquiring an additional 3,556,556 shares during the period. Cambiar Investors LLC bought a new stake in shares of Nutrien in the second quarter worth $166,998,000. Toronto Dominion Bank grew its holdings in shares of Nutrien by 94.6% in the first quarter. Toronto Dominion Bank now owns 5,494,159 shares of the company’s stock worth $289,969,000 after acquiring an additional 2,671,293 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp bought a new stake in shares of Nutrien in the first quarter worth $74,114,000. Finally, Thornburg Investment Management Inc. grew its holdings in shares of Nutrien by 91.7% in the first quarter. Thornburg Investment Management Inc. now owns 1,426,652 shares of the company’s stock worth $75,270,000 after acquiring an additional 682,387 shares during the period. 67.83% of the stock is owned by institutional investors.
Shares of NTR traded down $1.62 on Monday, reaching $51.90. The stock had a trading volume of 27,324 shares, compared to its average volume of 1,999,564. The firm has a market capitalization of $31.04 billion, a price-to-earnings ratio of 19.28, a price-to-earnings-growth ratio of 2.38 and a beta of 0.87. The company’s 50-day moving average price is $52.58. Nutrien has a 12-month low of $43.96 and a 12-month high of $58.99.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 17th. Shareholders of record on Monday, September 30th will be issued a $0.45 dividend. This is a positive change from Nutrien’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, September 27th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 3.47%. Nutrien’s dividend payout ratio (DPR) is presently 63.94%.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Article: What is a recession?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.